KLK3 and prostate cancer: Forty-five percent of the men with prostate cancer (9/20) demonstrated 100% positivity for PSA-markers, while 55% had a heterogeneous population of cancer cells (ICC-PSA-positive-CTC and ICC-PSA-negative-CTC) (Figure 1, Table 1).